ArticleJournal of enzyme inhibition and medicinal chemistry2024

Discovery of novel and potent dual-targeting AXL/HDAC2 inhibitors for colorectal cancer treatment via structure-based pharmacophore modelling, virtual screening, and molecular docking, molecular dynamics simulation studies, and biological evaluation.

Xiao Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.